NCT05791721View on ClinicalTrials.gov

Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 11, 2021

Primary Completion Date

December 26, 2022

Study Completion Date

December 26, 2022

Conditions
Surgical WoundPost Operative Pain
Interventions
DRUG

Etoricoxib 90 Mg Oral Tablet

Intervention will be applied one hour before surgical extraction of impacted mandibular third molar

DRUG

Dexamethasone 4mg

Intervention will be applied one hour before surgical extraction of impacted mandibular third molar

Trial Locations (1)

11000

School of Dental medicine, University of Belgrade, Belgrade

All Listed Sponsors
lead

University of Belgrade

OTHER

NCT05791721 - Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery | Biotech Hunter | Biotech Hunter